Sangamo Therapeutics, Inc. (SGMOQ)
0.1401
-0.01
(-6.60%)
USD |
OTCM |
Oct 13, 16:00
Sangamo Therapeutics EPS Diluted (TTM) : -0.383 for March 31, 2026
EPS Diluted (TTM) Chart
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -0.383 |
| December 31, 2025 | -0.4423 |
| September 30, 2025 | -0.4428 |
| June 30, 2025 | -0.2842 |
| March 31, 2025 | -0.3835 |
| December 31, 2024 | -0.5168 |
| September 30, 2024 | -0.745 |
| June 30, 2024 | -1.377 |
| March 31, 2024 | -1.856 |
| December 31, 2023 | -1.459 |
| September 30, 2023 | -1.435 |
| June 30, 2023 | -1.184 |
| March 31, 2023 | -0.8183 |
| December 31, 2022 | -1.244 |
| September 30, 2022 | -1.186 |
| June 30, 2022 | -1.178 |
| March 31, 2022 | -1.214 |
| December 31, 2021 | -1.234 |
| September 30, 2021 | -1.264 |
| June 30, 2021 | -0.9465 |
| March 31, 2021 | -0.8774 |
| December 31, 2020 | -0.9262 |
| September 30, 2020 | -0.6033 |
| June 30, 2020 | -0.8283 |
| March 31, 2020 | -0.8346 |
| Date | Value |
|---|---|
| December 31, 2019 | -0.8769 |
| September 30, 2019 | -1.096 |
| June 30, 2019 | -0.986 |
| March 31, 2019 | -0.8912 |
| December 31, 2018 | -0.7091 |
| September 30, 2018 | -0.6762 |
| June 30, 2018 | -0.70 |
| March 31, 2018 | -0.70 |
| December 31, 2017 | -0.70 |
| September 30, 2017 | -0.69 |
| June 30, 2017 | -0.81 |
| March 31, 2017 | -1.02 |
| December 31, 2016 | -1.02 |
| September 30, 2016 | -1.08 |
| June 30, 2016 | -0.94 |
| March 31, 2016 | -0.73 |
| December 31, 2015 | -0.58 |
| September 30, 2015 | -0.44 |
| June 30, 2015 | -0.42 |
| March 31, 2015 | -0.35 |
| December 31, 2014 | -0.39 |
| September 30, 2014 | -0.46 |
| June 30, 2014 | -0.46 |
| March 31, 2014 | -0.46 |
| December 31, 2013 | -0.47 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -2.243 |
| Oncolytics Biotech, Inc. | -0.2725 |
| Sarepta Therapeutics, Inc. | -2.898 |
| Anixa Biosciences, Inc. | -0.3099 |
| Mera Pharmaceuticals, Inc. | -- |